Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

147.65

+4.80 (3.36%)

as of Aug 13, 2026, 8:00:00 pm Market Open.

221 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 37 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) is experiencing a mix of skepticism and optimism driven by fears surrounding AI's potential impact on its services, particularly in the legal and accounting sectors. Despite these concerns, many analysts believe TRI’s proprietary data and established market position provide some insulation against AI disruption. The company recently reported solid earnings growth and is investing in share buybacks, indicating confidence in its future. Several experts view the current valuation as more attractive than before and see opportunities for long-term growth, while caution still exists due to valuation discussions and market sentiment. The firm's traditional business model continues to be seen as viable, and many believe it's well-positioned to integrate AI into its offerings, potentially enhancing its competitive advantage.

Consensus

Buy

Valuation

Undervalued

Similar

TMX,TMX

BUY ON WEAKNESS

Great defensive company. Subscription-based services to legal, accounting, and tax. Even in a recession, those sectors need access to data to do their jobs. It's all about owning it at the right price. Strong numbers last quarter. Always trades expensively. Intellectual assets have high returns with low capex. Not a bad entry here around $125. Consistent EPS growth. He's looking at it.

HOLD

They did a major restructuring but when they sold their business analytics business. Earnings have declined, but they sit on a lot of cash. Very well managed. Shares ran up during lockdowns. Pays a 2% dividend and trades at 9x. You can hold on, but wait and see what they do, like whether they will buy a new business like software or buyback shares. No need to panic.

BUY ON WEAKNESS

Really nice run, well deserved. PEG of 1, but doesn't trade at a lofty valuation. Likes it. Add on weakness, below $130.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A company that can slowly but surely compound capital. Buybacks and dividend increases will continue. Fundamentally, it is a strong company. On average a slower growth company, and trades at 40x forward earnings. Unlock Premium - Try 5i Free

BUY ON WEAKNESS

Absolutely should be on your buy list. Rough start to the year. Core business is tremendous with strong, organic growth. Over time, has become more shareholder friendly. Volatile. Future should provide share buybacks and dividend increases. Reasonable valuation, 18-19x cashflow.

SELL ON STRENGTH

Not impossible to get a bounce between now and April. But there are better neighbourhoods to focus on. A tough group. Market's moving away from this group to things that have an immediate impact from stronger pricing. No great pricing power.

DON'T BUY

Model price is $82. Moving sideways, and will keep doing so. Rich valuation. Yield is 1.4%, meager at best. Look farther afield for value. Leave the space alone.

PARTIAL SELL

If you've made money, take some off the table. He's not 100% sure there's huge upside from here. Quite acquisitive, so they could buy some growth. Big, stable businesses that will perform well over time. Valuation is extreme. Not attractive at these levels.

PARTIAL SELL

Includes great technology pieces. Not sure what the ceiling or floor is, as a lot is policy and interest rate driven. Dividend not growing at an attractive enough rate. If you've done well, perhaps reduce your position or just hold if you have a big capital gain. Not a buyer at these levels. Better value in other sectors.

HOLD

They sell database software to healthcare, legal, accounting, and others. Margins have kept ticking higher. Steady grower. Big moat, as the dominant provider of information. As long as it continues to perform, stay with it.

WATCH

Struggles with this. Earnings have remained largely unmoved from a fundamental point of view. Will acquisitions actually move the needle? Quite expensive for what it is. He's watching, but they'll have to show him the money before he'd be a buyer.

BUY ON WEAKNESS

Allan Tong’s Discover Picks TRI is a steady eddy operating in a (let's face it) stodgy business, but predictability preserves capital. TRI stock is reliable in that it keeps beating its quarters (the last four by comfortable margins) and trades at a PE of mere 8x. The dividend pays a safe, but modest 1.4%. Read Buying the Dip – A Stock Buying Opportunity for our full analysis.

HOLD

Great company. Must-have information for legal and tax. Not capital intensive, profitable. Stock's done well. She'd look at it on a pullback. Fully valued right now. Long-term hold. (Analysts’ price target is $141.00)

BUY ON WEAKNESS

They dominate in legal textbooks globally. Their business model is scalable. It's full valued now. She owns only a little of this.

BUY

The broader transition with unlocking value through content. There will be more users as the economy opens up on their application. This will give the stock a lift. The pay per user on the software is positive. A slow and stable companies with boughts of growth that is acquisition driven. A quality company.

Showing 61 to 75 of 718 entries

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)